# Biomat USA Inc – FDA Inspection, Feb 11, 2015

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/eef1fc32-b099-4b1a-9a4b-31a6d452f981
Source feed: FDA_Inspections

> FDA inspection 913423 of Biomat USA Inc, February 11, 2015. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 913423
- Company Name: Biomat USA Inc
- Inspection Date: 2015-02-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1114622 - 2019-12-20
- FDA Inspection 1041173 - 2018-02-02
- [FDA Inspection 816496 - 2013-01-31](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d2c1d5c1-19fb-4f0c-84c2-1347515a3439)
- FDA Inspection 706463 - 2011-01-20
- FDA Inspection 694728 - 2010-10-20

Company: https://www.keypedia.com/companies/biomat-usa-inc/81f33cad-5f73-4670-802a-d45be89af964

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d